BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 16827957)

  • 1. Therapeutic termination of second trimester pregnancies with low dose misoprostol.
    Liaquat NF; Javed I; Shuja S; Shoaib T; Bano K; Waheed S; Ansar A
    J Coll Physicians Surg Pak; 2006 Jul; 16(7):464-7. PubMed ID: 16827957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Success rate of second-trimester termination of pregnancy using misoprostol.
    Prachasilpchai N; Russameecharoen K; Borriboonhirunsarn D
    J Med Assoc Thai; 2006 Aug; 89(8):1115-9. PubMed ID: 17048418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of oral versus vaginal misoprostol for mid-trimester pregnancy termination.
    Mahjabeen ; Khawaja NP; Rehman R
    J Coll Physicians Surg Pak; 2009 Jun; 19(6):359-62. PubMed ID: 19486574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic termination of second trimester pregnancies with intrauterine fetal death with 400 micrograms of oral misoprostol.
    Pongsatha S; Tongsong T
    J Obstet Gynaecol Res; 2004 Jun; 30(3):217-20. PubMed ID: 15210046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea. A prospective randomized trial].
    Hidar S; Fekih M; Chaïeb A; Bibi M; Mellouli R; Khaïri H
    J Gynecol Obstet Biol Reprod (Paris); 2001 Sep; 30(5):439-43. PubMed ID: 11598557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic termination of second trimester pregnancy with vaginal misoprostol.
    Pongsatha S; Tongsong T; Suwannawut O
    J Med Assoc Thai; 2001 Apr; 84(4):515-9. PubMed ID: 11460962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT; Papatsonis DN; Heydanus R
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-trimester pregnancy termination: comparison of three different methods.
    Makhlouf AM; Al-Hussaini TK; Habib DM; Makarem MH
    J Obstet Gynaecol; 2003 Jul; 23(4):407-11. PubMed ID: 12881083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second trimester pregnancy termination with 800 mcg vaginal misoprostol.
    Pongsatha S; Tongsong T
    J Med Assoc Thai; 2001 Jun; 84(6):859-63. PubMed ID: 11556466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
    Tang OS; Lau WN; Chan CC; Ho PC
    BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
    Herabutya Y; Chanrachakul B; Punyavachira P
    BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A viable alternative to surgical vacuum aspiration: repeated doses of intravaginal misoprostol over 9 hours for medical termination of pregnancies up to eight weeks.
    Singh K; Fong YF; Dong F
    BJOG; 2003 Feb; 110(2):175-80. PubMed ID: 12618162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
    Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
    Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks.
    Bhattacharjee N; Saha SP; Ghoshroy SC; Bhowmik S; Barui G
    Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):165-71. PubMed ID: 18366490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Termination of pregnancy in patients with previous cesarean section.
    Mazouni C; Provensal M; Porcu G; Guidicelli B; Heckenroth H; Gamerre M; Bretelle F
    Contraception; 2006 Mar; 73(3):244-8. PubMed ID: 16472563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misoprostol moistened with acetic acid or saline for second trimester pregnancy termination: a randomized prospective double-blind trial.
    Yilmaz B; Kelekci S; Ertas IE; Kahyaoglu S; Ozel M; Sut N; Danisman N
    Hum Reprod; 2005 Nov; 20(11):3067-71. PubMed ID: 16037107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
    Goh SE; Thong KJ
    Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Termination of second-trimester pregnancy with intracervicovaginal misoprostol.
    Srisomboon J; Tongsong T; Pongpisuttinun S
    J Med Assoc Thai; 1997 Apr; 80(4):242-6. PubMed ID: 9175393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-trimester termination of pregnancy by extra-amniotic prostaglandin F2alpha or endocervical misoprostol. A comparative study.
    Ghorab MN; El Helw BA
    Acta Obstet Gynecol Scand; 1998 Apr; 77(4):429-32. PubMed ID: 9598952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.